<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Duckworth Valdez | Activity</title>
	<link>https://toxicdolls.com/members/nationhome9/activity/</link>
	<atom:link href="https://toxicdolls.com/members/nationhome9/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Duckworth Valdez.</description>
	<lastBuildDate>Mon, 04 May 2026 08:35:57 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">e55d92e103ac66bbee9cc1b121467cbd</guid>
				<title>Duckworth Valdez posted an update: NS disease control rate was 90% (95% CI, 85%-93%; [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/7479/</link>
				<pubDate>Sun, 22 Jun 2025 11:05:32 +0000</pubDate>

									<content:encoded><![CDATA[<p>NS disease control rate was 90% (95% CI, 85%-93%; n = 246). Included studies reported complete intracranial response rates of 7% to 23%, median best decrease in intracranial lesion size of -40% to -64%, and Common Terminology Criteria for Adverse Events (version 3.0) grade 3 or higher adverse event rates of 19% to 39%. Subgroup analyses did not&hellip;<span class="activity-read-more" id="activity-read-more-7479"><a href="https://toxicdolls.com/activity-2/p/7479/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d0e457c583ff6a708f10f9ee3e17ce6f</guid>
				<title>Duckworth Valdez posted an update: No relapse of IBD has been observed during chemotherapy. The [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/6463/</link>
				<pubDate>Sat, 21 Jun 2025 11:46:15 +0000</pubDate>

									<content:encoded><![CDATA[<p>No relapse of IBD has been observed during chemotherapy. The IBD relapse rate at the end of the last chemotherapy cycle was 23% at 3 years (95% CI 11%-39%) in the overall population. CONCLUSION In this large cohort, the prognosis for lymphomas occurring in IBD appears to be good and similar to what is expected, irrespective of the exposure to&hellip;<span class="activity-read-more" id="activity-read-more-6463"><a href="https://toxicdolls.com/activity-2/p/6463/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ffa3877a3cc84b7c4d0b293fd7ec39f6</guid>
				<title>Duckworth Valdez posted an update: Furthermore, nitidine also showed significant, although weak, [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/5699/</link>
				<pubDate>Fri, 20 Jun 2025 17:55:48 +0000</pubDate>

									<content:encoded><![CDATA[<p>Furthermore, nitidine also showed significant, although weak, antiaggregating activity towards amyloid-β self-aggregation.Cosmetics has recently focused on biobased skin-compatible materials. Materials from natural sources can be used to produce more sustainable skin contact products with enhanced bioactivity. Surface functionalization using&hellip;<span class="activity-read-more" id="activity-read-more-5699"><a href="https://toxicdolls.com/activity-2/p/5699/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">78839c39a7e78ef4f6d072f52bf0b0ef</guid>
				<title>Duckworth Valdez became a registered member</title>
				<link>https://toxicdolls.com/activity-2/p/5653/</link>
				<pubDate>Fri, 20 Jun 2025 17:27:37 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>